ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,284.91
0.20%
Dow Jones
42,170.13
0.61%
Gold vs US Dollar
2,671.515
0.54%
Brent Oil
71.015
-2.97%
Bitcoin
65,239.14
3.34%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tempest Therpeutics Inc (TPST)

  7. Tempest Therpeutics Inc (TPST) News

Tempest Therpeutics (TPST)

Tempest Therpeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TPST
DateTimeSourceHeadlineSymbolCompany
20/09/202421:30GlobeNewswire Inc.Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
18/09/202413:00GlobeNewswire Inc.Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory AffairsNASDAQ:TPSTTempest Therpeutics Inc
05/09/202413:00GlobeNewswire Inc.Tempest to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TPSTTempest Therpeutics Inc
23/08/202421:30GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
21/08/202413:00GlobeNewswire Inc.Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality AssuranceNASDAQ:TPSTTempest Therpeutics Inc
15/08/202413:00GlobeNewswire Inc.Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular CarcinomaNASDAQ:TPSTTempest Therpeutics Inc
13/08/202413:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TPSTTempest Therpeutics Inc
13/08/202401:59Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
09/08/202420:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TPSTTempest Therpeutics Inc
08/08/202421:56GlobeNewswire Inc.Tempest Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TPSTTempest Therpeutics Inc
08/08/202421:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TPSTTempest Therpeutics Inc
08/08/202421:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
19/07/202421:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TPSTTempest Therpeutics Inc
08/07/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
20/06/202413:32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TPSTTempest Therpeutics Inc
20/06/202413:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
20/06/202413:00GlobeNewswire Inc.Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control ArmNASDAQ:TPSTTempest Therpeutics Inc
18/06/202423:22GlobeNewswire Inc.Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular CarcinomaNASDAQ:TPSTTempest Therpeutics Inc
14/06/202423:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TPSTTempest Therpeutics Inc
14/06/202421:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
07/06/202409:30GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
21/05/202413:00GlobeNewswire Inc.Tempest to Participate in Upcoming Investor ConferencesNASDAQ:TPSTTempest Therpeutics Inc
13/05/202421:54Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TPSTTempest Therpeutics Inc
09/05/202421:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TPSTTempest Therpeutics Inc
09/05/202421:29GlobeNewswire Inc.Tempest Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TPSTTempest Therpeutics Inc
09/05/202421:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TPSTTempest Therpeutics Inc
26/04/202421:05GlobeNewswire Inc.Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TPSTTempest Therpeutics Inc
09/04/202413:00GlobeNewswire Inc.Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual MeetingNASDAQ:TPSTTempest Therpeutics Inc
04/04/202413:00GlobeNewswire Inc.Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research CommunicationsNASDAQ:TPSTTempest Therpeutics Inc
19/03/202420:25GlobeNewswire Inc.Tempest Reports Year End 2023 Financial Results and Provides Business UpdateNASDAQ:TPSTTempest Therpeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TPST

Your Recent History

NASDAQ
KALV
KalVista Pharmaceuticals
COIN
FOXXETH
Star Foxx
NASDAQ
AAZYQXX
Bank of Montreal Capped ...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved